Assetmark Inc. Boosts Position in Agilent Technologies, Inc. $A

Assetmark Inc. increased its position in Agilent Technologies, Inc. (NYSE:A) by 6.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 221,291 shares of the medical research company’s stock after purchasing an additional 12,997 shares during the quarter. Assetmark Inc. owned approximately 0.08% of Agilent Technologies worth $28,403,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Capital A Wealth Management LLC lifted its holdings in Agilent Technologies by 10,600.0% during the second quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock worth $25,000 after buying an additional 212 shares during the period. Davis Capital Management bought a new stake in shares of Agilent Technologies in the 3rd quarter valued at about $28,000. Physician Wealth Advisors Inc. boosted its holdings in shares of Agilent Technologies by 490.0% in the 3rd quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock valued at $30,000 after buying an additional 196 shares in the last quarter. State of Wyoming purchased a new position in shares of Agilent Technologies in the 2nd quarter worth approximately $35,000. Finally, SJS Investment Consulting Inc. raised its stake in shares of Agilent Technologies by 2,836.4% during the 3rd quarter. SJS Investment Consulting Inc. now owns 323 shares of the medical research company’s stock worth $41,000 after acquiring an additional 312 shares in the last quarter.

Analyst Ratings Changes

A has been the topic of a number of recent analyst reports. Morgan Stanley started coverage on shares of Agilent Technologies in a research note on Tuesday, December 2nd. They set an “overweight” rating on the stock. Citigroup boosted their price objective on shares of Agilent Technologies from $165.00 to $185.00 and gave the company a “buy” rating in a report on Tuesday, November 25th. HSBC started coverage on Agilent Technologies in a research note on Tuesday, January 20th. They issued a “buy” rating and a $180.00 target price for the company. Bank of America boosted their price target on Agilent Technologies from $150.00 to $165.00 and gave the company a “neutral” rating in a research note on Tuesday, November 25th. Finally, JPMorgan Chase & Co. lifted their target price on Agilent Technologies from $165.00 to $180.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, Agilent Technologies presently has an average rating of “Moderate Buy” and an average price target of $164.50.

Agilent Technologies Price Performance

NYSE:A opened at $125.80 on Friday. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $160.27. The stock has a market cap of $35.58 billion, a PE ratio of 27.53, a P/E/G ratio of 3.63 and a beta of 1.30. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.52 and a current ratio of 1.96. The stock has a 50 day moving average price of $137.84 and a 200 day moving average price of $135.30.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Monday, November 24th. The medical research company reported $1.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.58 by $0.01. The firm had revenue of $1.86 billion during the quarter, compared to analyst estimates of $1.83 billion. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. Agilent Technologies’s quarterly revenue was up 9.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.46 earnings per share. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Equities research analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 22nd. Stockholders of record on Tuesday, March 31st will be paid a $0.255 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.32%.

Insider Activity at Agilent Technologies

In other news, VP Rodney Gonsalves sold 3,000 shares of the stock in a transaction on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total value of $464,970.00. Following the sale, the vice president directly owned 31,846 shares in the company, valued at approximately $4,935,811.54. This trade represents a 8.61% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Padraig Mcdonnell sold 911 shares of the firm’s stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $143.24, for a total transaction of $130,491.64. Following the completion of the sale, the chief executive officer owned 32,058 shares in the company, valued at $4,591,987.92. The trade was a 2.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.